Autocrine regulation of TGF-β1-induced cell migration by exocytosis of ATP and activation of P2 receptors in human lung cancer cells

Journal of Cell Science

Volumn 125, Issue 21, 2012, Pages 5051-5060

  Takai, Erina ^a   Tsukimoto, Mitsutoshi ^a   Harada, Hitoshi ^b   Sawada, Keisuke ^c   Moriyama, Yoshinori ^c   Kojima, Shuji ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

ATP; Autocrine signaling; Cell migration; Exocytosis; P2 receptor; TGF 1

Indexed keywords

ACTIN; ADENOSINE TRIPHOSPHATE; PURINERGIC P2 RECEPTOR ANTAGONIST; PURINERGIC P2X7 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ACTIN POLYMERIZATION; ARTICLE; AUTOCRINE EFFECT; CANCER CELL; CELL MIGRATION; CYTOSOL; EXOCYTOSIS; GENE SILENCING; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; PROTEIN SECRETION;

ACTIN CYTOSKELETON; ADENOSINE TRIPHOSPHATE; AUTOCRINE COMMUNICATION; CELL LINE, TUMOR; CELL MOVEMENT; EXOCYTOSIS; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; NUCLEOTIDE TRANSPORT PROTEINS; RECEPTORS, PURINERGIC P2; RECEPTORS, PURINERGIC P2X7; RNA, SMALL INTERFERING; SECRETORY VESICLES; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84872255267     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.104976     Document Type: Article

References (43)

1. Burnstock, G. (2006). Purinergic signalling. Br. J. Pharmacol. 147, S172-S181.
2. Burnstock, G. (2009). Purinergic signalling: past, present and future. Braz. J. Med. Biol. Res. 42, 3-8.
3. Edlund, S., Landström, M., Heldin, C. H. and Aspenström, P. (2002). Transforming growth factorΒeta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. Mol. Biol. Cell 13, 902-914.
4. Gal, A., Sjöblom, T., Fedorova, L., Imreh, S., Beug, H. and Moustakas, A. (2008). Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. Oncogene 27, 1218-1230.
5. Gilchrist, L. S., Cain, D. M., Harding-Rose, C., Kov, A. N., Wendelschafer-Crabb, G., Kennedy, W. R. and Simone, D. A. (2005). Re-organization of P2X3 receptor localization on epidermal nerve fibers in a murine model of cancer pain. Brain Res. 1044, 197-205.
6. Go, C., Li, P. and Wang, X. J. (1999). Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis. Cancer Res. 59, 2861-2868.
7. Hasegawa, Y., Takanashi, S., Kanehira, Y., Tsushima, T., Imai, T. and Okumura, K. (2001). Transforming growth factorΒeta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. Cancer 91, 964-971.
8. Hisadome, K., Koyama, T., Kimura, C., Droogmans, G., Ito, Y. and Oike, M. (2002). Volume-regulated anion channels serve as an auto/paracrine nucleotide release pathway in aortic endothelial cells. J. Gen. Physiol. 119, 511-520.
9. Huang, C., Jacobson, K. and Schaller, M. D. (2004). MAP kinases and cell migration. J. Cell Sci. 117, 4619-4628.
10. Humphreys, B. D., Rice, J., Kertesy, S. B. and Dubyak, G. R. (2000). Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor. J. Biol. Chem. 275, 26792-26798.
11. Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J. and Hill, C. S. (2002). SB-431542 is a potent and specific inhibitor of transforming growth factorΒeta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62, 65-74.
12. Iwatsuki, K., Ichikawa, R., Hiasa, M., Moriyama, Y., Torii, K. and Uneyama, H. (2009). Identification of the vesicular nucleotide transporter (VNUT) in taste cells. Biochem. Biophys. Res. Commun. 388, 1-5.
13. Jelassi, B., Chantôme, A., Alcaraz-Pérez, F., Baroja-Mazo, A., Cayuela, M. L., Pelegrin, P., Surprenant, A. and Roger, S. (2011). P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness. Oncogene 30, 2108-2122.
14. Lee, C. (1971). A fluorescent probe of the hydrogen ion concentration in ethylenediaminetetraacetic acid particles of beef heart mitochondria. Biochemistry 10, 4375-4381.
15. Lindmo, K. and Stenmark, H. (2006). Regulation of membrane traffic by phosphoinositide 3-kinases. J. Cell Sci. 119, 605-614.
16. Michel, A. D., Chambers, L. J., Clay, W. C., Condreay, J. P., Walter, D. S. and Chessell, I. P. (2007). Direct labelling of the human P2X7 receptor and identification of positive and negative cooperativity of binding. Br. J. Pharmacol. 151, 84-95.
17. Miyaki, M., Iijima, T., Konishi, M., Sakai, K., Ishii, A., Yasuno, M., Hishima, T., Koike, M., Shitara, N., Iwama, T. et al. (1999). Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 18, 3098-3103.
18. Morelli, A., Chiozzi, P., Chiesa, A., Ferrari, D., Sanz, J. M., Falzoni, S., Pinton, P., Rizzuto, R., Olson, M. F. and Di Virgilio, F. (2003). Extracellular ATP causes ROCK I-dependent bleb formation in P2X7-transfected HEK293 cells. Mol. Biol. Cell 14, 2655-2664.
19. Mumm, J. B. and Oft, M. (2008). CytokineΒased transformation of immune surveillance into tumor-promoting inflammation. Oncogene 27, 5913-5919.
20. Narumiya, S., Tanji, M. and Ishizaki, T. (2009). Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev. 28, 65-76.
21. Neil, J. R., Johnson, K. M., Nemenoff, R. A. and Schiemann, W. P. (2008). Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGFΒeta through a PGE2-dependent mechanisms. Carcinogenesis 29, 2227-2235.
22. Nelson, D. W., Gregg, R. J., Kort, M. E., Perez-Medrano, A., Voight, E. A., Wang, Y., Grayson, G., Namovic, M. T., Donnelly-Roberts, D. L., Niforatos, W. et al. (2006). Structure-activity relationship studies on a series of novel, substituted 1Βenzyl-5-phenyltetrazole P2X7 antagonists. J. Med. Chem. 49, 3659-3666.
23. Olson, M. F. and Sahai, E. (2009). The actin cytoskeleton in cancer cell motility. Clin. Exp. Metastasis 26, 273-287.
24. Pangrsic, T., Potokar, M., Stenovec, M., Kreft, M., Fabbretti, E., Nistri, A., Pryazhnikov, E., Khiroug, L., Giniatullin, R. and Zorec, R. (2007). Exocytotic release of ATP from cultured astrocytes. J. Biol. Chem. 282, 28749-28758.
25. Pellegatti, P., Falzoni, S., Pinton, P., Rizzuto, R. and Di Virgilio, F. (2005). A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion. Mol. Biol. Cell 16, 3659-3665.
26. Pellegatti, P., Raffaghello, L., Bianchi, G., Piccardi, F., Pistoia, V. and Di Virgilio, F. (2008). Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS ONE 3, e2599.
27. Rahimi, R. A. and Leof, E. B. (2007). TGFΒeta signaling: a tale of two responses. J. Cell. Biochem. 102, 593-608.
28. Sabirov, R. Z., Dutta, A. K. and Okada, Y. (2001). Volume-dependent ATP-conductive large-conductance anion channel as a pathway for swelling-induced ATP release. J. Gen. Physiol. 118, 251-266.
29. Sathe, M. N., Woo, K., Kresge, C., Bugde, A., Luby-Phelps, K., Lewis, M. A. and Feranchak, A. P. (2011). Regulation of purinergic signaling in biliary epithelial cells by exocytosis of SLC17A9-dependent ATP-enriched vesicles. J. Biol. Chem. 286, 25363-25376.
30. Sawada, K., Echigo, N., Juge, N., Miyaji, T., Otsuka, M., Omote, H., Yamamoto, A. and Moriyama, Y. (2008). Identification of a vesicular nucleotide transporter. Proc. Natl. Acad. Sci. USA 105, 5683-5686.
31. Schafer, R., Sedehizade, F., Welte, T. and Reiser, G. (2003). ATP- and UTP-activated P2Y receptors differently regulate proliferation of human lung epithelial tumor cells. Am. J. Physiol. Lung Cell Mol. Physiol. 285, 376-385.
32. Siegel, P. M., Shu, W., Cardiff, R. D., Muller, W. J. and Massagué, J. (2003). Transforming growth factor beta signaling impairs Neu-induced mammary tumor-igenesis while promoting pulmonary metastasis. Proc. Natl. Acad. Sci. USA 100, 8430-8435.
33. Stagg, J. and Smyth, M. J. (2010). Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 29, 5346-5358.
34. Stout, C. E., Costantin, J. L., Naus, C. C. and Charles, A. C. (2002). Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J. Biol. Chem. 277, 10482-10488.
35. Südhof, T. C. and Rothman, J. E. (2009). Membrane fusion: grappling with SNARE and SM proteins. Science 323, 474-477.
36. Tokunaga, A., Tsukimoto, M., Harada, H., Moriyama, Y. and Kojima, S. (2010). Involvement of SLC17A9-dependent vesicular exocytosis in the mechanism of ATP release during T cell activation. J. Biol. Chem. 285, 17406-17416.
37. Tsukimoto, M., Harada, H. and Degawa, M. (2007). Role of purinoceptors in immune-mediated disease (therapies targeting the P2X7 receptor). Drug Discov. Today Ther. Strateg. 1, 33-37.
38. Tu, M. T., Luo, S. F., Wang, C. C., Chien, C. S., Chiu, C. T., Lin, C. C. and Yang, C. M. (2000). P2Y(2) receptor-mediated proliferation of C(6) glioma cells via activation of Ras/Raf/MEK/MAPK pathway. Br. J. Pharmacol. 129, 1481-1489.
39. Wang, Y., Roman, R., Lidofsky, S. D. and Fitz, J. G. (1996). Autocrine signaling through ATP release represents a novel mechanism for cell volume regulation. Proc. Natl. Acad. Sci. USA 93, 12020-12025.
40. Wei, W., Ryu, J. K., Choi, H. B. and McLarnon, J. G. (2008). Expression and function of the P2X(7) receptor in rat C6 glioma cells. Cancer Lett. 260, 79-87.
41. Wendt, M. K., Allington, T. M. and Schiemann, W. P. (2009). Mechanisms of the epithelial-mesenchymal transition by TGFΒeta. Future Oncol. 5, 1145-1168.
42. Yilmaz, M. and Christofori, G. (2010). Mechanisms of motility in metastasizing cells. Mol. Cancer Res. 8, 629-642.
43. Zhang, Z., Chen, G., Zhou, W., Song, A., Xu, T., Luo, Q., Wang, W., Gu, X. S. and Duan, S. (2007). Regulated ATP release from astrocytes through lysosome exocytosis. Nat. Cell Biol. 9, 945-953.